Lantern Pharma Inc Aktie News
3,38 $
2,31 %
vorgestern
Nasdaq,
14. November, 22:00 Uhr
tracken
Lantern Pharma Inc Aktie News
Neutral
Seeking Alpha
●
3 Tage alt
Lantern Pharma Inc. ( LTRN ) Q3 2025 Earnings Call November 13, 2025 9:00 AM EST Company Participants Panna Sharma - President, CEO & Director David Margrave - CFO & Secretary Presentation Operator Good morning, and welcome to our third quarter 2025 earnings call. As a reminder, this call is being recorded [Operator Instructions].
Neutral
Business Wire
●
3 Tage alt
DALLAS--(BUSINESS WIRE)--Q3 Press Release - BTM.
Neutral
Business Wire
●
10 Tage alt
DALLAS--(BUSINESS WIRE)--Lantern Pharma to Report Third Quarter 2025 Operating & Financial Results on November 13th, 2025 at 9:00 a.m. ET.
Neutral
Business Wire
●
17 Tage alt
DALLAS--(BUSINESS WIRE)--Lantern Pharma to Present AI-Driven Cancer Drug Development & Research Platforms at Inaugural AI for Biology and Medicine Symposium at UNT.
Neutral
Business Wire
●
19 Tage alt
DALLAS--(BUSINESS WIRE)--LP-284 at 25th LL&M Congress & CMR.
Neutral
Business Wire
●
23 Tage alt
DALLAS--(BUSINESS WIRE)--Lantern Pharma to Present at the ThinkEquity Conference in NYC on October 30, 2025.
Neutral
Business Wire
●
2 Monate alt
DALLAS--(BUSINESS WIRE)--Clinical Trial Results, LP-184.
Neutral
GlobeNewsWire
●
2 Monate alt
AUSTIN, Texas, Sept. 10, 2025 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The BioMedWire Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels.
Kostenlos registrieren
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.
